Most of patients have not sought medical advice China's rheumatoid disease into a disability in time

Most of patients have not sought medical advice China's rheumatoid disease into a disability in time
Cable of September 10 of www.chinanews.com Beijing (reporter Zeng LiMing) Rheumatoid disease is having illness coming on to increase in China Mainland year by year at present, the most serious rheumatoid arthritis among them, patients have already exceeded 4,400,000, the patient of inflammation of strong straightforward backbone is up to 3,900,000. If can not get and does not treat effectively in time, a lot of patients will cause the disability, lose work and viability. This is known by Chinese Medical Association's rheumatism credit General Board one and presented warning that a professor puts forward today in spring with respect. He is at Chinese Medical Association for rheumatism credit will, rheumatisms Asian-Pacific alliance and Pfizer hold " My rheumatoid arthritis day " Reach the standard grade by website and global first rheumatism the intersection of disease and the intersection of living beings and therapeutic the intersection of medicine and the intersection of kindness and profit list on China at the news conference pointing out: Arthritis patient develops rheumatoid with the condition, joint ossicle will take place and destroy, damage permanently, deform, weaken the self-care ability of life. See more teenagers' male strong straightforward backbone inflammation, will make the patient present pain and stiff symptom, the backbone is given much trouble and expands to the hip joint, knee joint,etc. peripheral joint, cause the function obstacle. The investigation reveals, 50% of the rheumatoid arthritis patients develop into the intermediate function in 2 years after diagnosis and lose. He emphasizes, because the cognitive intensity to rheumatism disease of China Mainland is relatively low, clinical diagnosis delay, treating improperly is very common; Traditional the intersection of rheumatism and therapeutic medicine have, relieve symptom, tackle a problem on the surface, not at the root and play the intersection of result and slow, the intersection of side effect and shortcoming such as being loud only too. And adopt the new biologic product to treat in early days, can help the patient to control the condition, prevent the condition from worsening, make the patient return to healthy life. Manage guidance in order to provide scientific making a diagnosis and disease for Chinese patient, Chinese Medical Association's rheumatism credit will be under the circumstances that the Asian-Pacific rheumatism alliance advocate, have run " My rheumatoid arthritis day websites " . The Chinese webpage of this website reaches the standard grade formally today, the patient can pass and fill in the interactive questionnaire, get the individualized health control scheme that a doctor offers, guide and make a diagnosis and live. It is reported, national food medicines in China supervise the administration bureau already sanctioning introducing the medicine kindness profit of new biological treatment. This medicine got approval of U.S.A. since 1998 and was used in the clinical bed, already more than 80 countries used in the whole world. (End)

|